Russia expected to start post-registration trials of its second COVID-19 vaccine on 15 November 2020

MLA

“Russia Expected to Start Post-Registration Trials of Its Second COVID-19 Vaccine on 15 November 2020.” M2 Pharma, 11 Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.641178355&authtype=sso&custid=ns315887.

APA

Russia expected to start post-registration trials of its second COVID-19 vaccine on 15 November 2020. (2020, November 11). M2 Pharma.

Chicago

M2 Pharma. 2020. “Russia Expected to Start Post-Registration Trials of Its Second COVID-19 Vaccine on 15 November 2020,” November 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.641178355&authtype=sso&custid=ns315887.